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ABSTRACT 
Objective: In recent era, medical science has turned to a variety of novel products and technologies to halt the spread of infections. The most 
promising and effective antimicrobial agents being embraced by modern medical science today is silver. With increasing drug-resistance and 
growing concern regarding the over-prescribing of antibiotics, there has been a resurgent interest in the use of antimicrobial silver. Unlike 
antibiotics, silver appears to be immune to resistance. Thus, the conjugation of antibiotic with silver nanoparticles would prevent development of 
resistance of microbes and increase the antimicrobial property of the antibiotic. 
Methods: In this manuscript, extracellular biological synthesis of silver nanoparticles was made from Trametes sp. The characterization of the 
nanoparticles was carried out as well as its antibiotic efficacy was evaluated in addition to the antibiotic combination.  
Results: Initially the fungal cell filtrate was challenged with 1Mm AgNO3 solution, in a 250 ml Erlenmeyer flask and agitated at 30 °C in dark for 72 
h under static conditions at 200 rpm and the silver nanoparticle production was monitored by the change in color and later it was subjected to 
optical measurements by UV-Vis spectrophotometer. The characters of these silver nanoparticles were further studied by Fourier Transform 
Infrared (FTIR) Spectroscopy, SEM and TEM studies. The nanoparticles produced during the study period were found to have wider antibacterial 
property and also it showed the enhanced efficacy in combination with ceftriaxone and ofloxacin against Salmonella sp.  
Conclusion: The synergistic mode of antibiosis in between nanoparticles synthesized from Trametes sp. and ceftriaxone, ofloxacin
Keywords: Trametes sp, Mycosynthesis, Silver nanoparticles, Antibacterial activity, Antibiotics. 
 was found to be 
more effective against Salmonella sp. in the current study. 
 
INTRODUCTION 
Enteric fever remains an important public health problem in many 
countries of the world. In recent years, an increasing number of 
salmonellosis outbreaks have been recorded around the world, and 
probably there should be more cases that were not detected or 
reported [1]. Many different types of Salmonella exist, some of which 
cause illness in both animals and people, and some types cause 
illness in animals but not in people. The various forms of Salmonella 
that can infect people are referred to as serotypes, which are very 
closely related microorganisms that share certain structural 
features. Some serotypes are only present in certain parts of the 
world. There is considerable overlap in symptoms, although typhoid 
is the more severe and long-lasting disease, and is the one most 
likely to result in death if prompt treatment is not given. The name 
typhoid means 'resembling typhus' and was chosen because of the 
occurrence of neuropsychiatric symptoms.  
Typhoid fever is endemic in developing countries, especially in 
Southeast Asia and Africa. Salmonella gastroenteritis is usually a 
self-limiting disease. Fluid and electrolyte replacement may be 
indicated in severe cases. Because antibiotics do not appear to 
shorten the duration of symptoms and may actually prolong the 
duration of convalescent carriage, they are not routinely used to 
treat uncomplicated non typhoidal Salmonella gastroenteritis. 
Current recommendations are that antibiotics be reserved for 
patients with severe disease or patients who are at a high risk for 
invasive disease [2]. Historically, recommended regimens for the 
treatment of typhoid fever included ampicillin, trimethoprim-
sulfamethoxazole, or chloramphenicol. Despite the discovery of new 
antibiotics, treatment of intracellular infections often fails to 
eradicate the pathogens completely. One major reason is that many 
antimicrobials are difficult to transport through cell membranes and 
have low activity in the cells. There by imposing negligible inhibitory 
or bactericidal effects on the intracellular bacteria. In addition, 
antimicrobial toxicity to healthy tissues poses a significant limitation 
to their use [3]. Therefore, the delivery of the drug to the bacterial 
cells is currently a big challenge to the clinicians. This is on top of the 
problems posed by the emerging Multi-Drug Resistant species. 
Moreover, reduced membrane permeability of microorganisms has 
been cited as a key mechanism of resistance to antibiotics [4]. 
Emerging drug resistance over the past 40 y has limited the 
usefulness of these antibiotics. Presently, quinolone, macrolide, and 
third-generation cephalosporin antibiotics are preferred for empiric 
therapy pending sensitivities. Unfortunately, sensitivity to 
quinolones has been steadily declining; some S. enterica serovar 
Typhi strains resistant to fluoroquinolones have already been 
reported [5-7].  
Further, several failures of clinical treatment of typhoid patients 
with ciprofloxacin and other fluoroquinolones have also been 
reported [8, 9]. Nanotechnology is one of the most fascinating and 
rapidly advancing sciences and possesses potential to revolutionize 
many disciplines of science, technology, medicine and agriculture if 
exploited properly [10]. The use of nanotechnology in medicine 
offers some exciting possibilities. Some techniques are only 
imagined, while others are at various stages of testing, or actually 
being used today. Rapid developments at the intersection of 
nanotechnology and controlled drug delivery have triggered 
exceptional growth in treating various diseases. As a result, over the 
past decade, nanotechnology has contributed tremendously to 
controlling drug delivery for treating various diseases, and in many 
cases, has led to increased activity compared to the existing drugs 
[11]. In recent decades, there has been increasing interest in 
nanotechnology from fungi, which are expected to produce high 
level of silver nanoparticles. Because of their rapid growth and high 
rate of production, fungi are used as bio-manufacturing units, which 
will provide an added benefit in being easy to use as compared to 
other microbes. The combination of antibiotics and metal 
nanoparticles could increase the antibiotic efficacy against resistant 
pathogens. Nanoparticle-antibiotic conjugates lower the amount of 
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both agents in the concentration, which reduces harmfulness and 
increases antimicrobial properties. These conjugates were effective 
against resistant bacteria species due to this conjugation; the 
concentrations of antibiotics were increased at the place of 
antibiotic-microbe interaction and thus accelerate the binding 
between microbes and antibiotics [12]. For this reason, the present 
research was carried out for biological synthesis of nanoparticles 
and their use in decreasing the concentration of antibiotics. The 
reduction of side effects and cost-effectiveness was also considered. 
The novelty of the work lies in the fact that we have used the culture 
filtrate to develop a simple, cost-effective, biocompatible, and an 
ecofriendly approach for the extracellular biological synthesis of 
silver nanoparticles using Trametes sp. The study involved the 
systematic analysis of the antibacterial activity of the biologically 
prepared silver nanoparticles against Salmonella sp. We also 
investigated the effect of the combination of antibiotics with AgNPs 
against Salmonella sp. It is industrially captivating and viable. This 
paper focuses mainly on the current research for increasing anti-
salmonella performance of antibiotics by means of nanotechnology. 
It is clear that such systems may improve the antibiotic efficacy by 
increasing the drug concentration with the attachment of the nano-
particles in the surrounding of the bacteria. 
MATERIALS AND METHODS 
Chemicals 
Silver nitrate (99 % pure) was purchased from Sigma-Aldrich, India. 
Nutrient broth, Malt extract and glucose were supplied by Hi-Media, 
India. 
White rot fungi 
Trametes sp. used in this study was isolated from Bodhan Forest 
Nizamabad District, Telangana, India. It was grown and maintained 
at 35 oC±2 oC on Malt Extract Agar medium (MEA: Malt extract-15 
gm, NH4Cl 1 gm, K2HPO4-1 gm, Citric acid 15N per 1000 ml of 
distilled water). 
Bacterial cultures  
Salmonella typhi and Salmonella paratyphi were procured from the 
Microbial Type Collection (MTCC) center, IMTECH, Chandigargh, 
India. 
Biosynthesis of silver nanoparticles 
For the synthesis of silver nanoparticles, the white rot fungi were 
inoculated in MG media (Malt extract-5.0 g, Glucose-10.0 g, Distilled 
water-1000 ml, pH-6.0) in Erlenmeyer flasks incubated at 30 °C on a 
shaker (180 rpm) for 48 h. The biomass was filtered using Whatman 
filter paper (No.1) and the silver nanoparticles were synthesized 
extra cellulary by challenging the culture filtrate with 1 mM final 
concentration of silver nitrate AgNO3, in a 250 ml Erlenmeyer flask 
and agitated at 30 °C in dark for 48 h under static conditions at 200 
rpm and the silver nanoparticle production was monitored. Control 
(without the silver ion, only culture) was also run along with the 
experimental flask.  
Characterization of silvernano particles  
UV-Vis spectroscopy analysis 
UV-Vis spectral analysis was done by using (ELICO SL-159 
Spectrophotometer) in the range 350-470 nm. The reduction of pure 
silver ions was monitored by measuring the UV-Vis spectrum of the 
reaction medium at 48 h of incubation. 
FTIR analysis of silver nanoparticles 
FTIR analysis was done using (Digital Excalibur 3000 series, Japan) 
in diffuse reflectance mode (DRS-800) in the range of 400-4000 cm-1 
at a resolution of 4 cm-1 of the Ag-NPs from fungus extracted 
samples [13]. 
SEM analysis of silver nanoparticles  
Scanning Electron Microscopic (SEM) analysis was done by (JOEL-
Model 6390). Thin films of the sample were prepared on a carbon 
coated gird, a very small amount of the specimen on the sample 
holder was placed extra solution was removed using a blotting 
paper, and then the film on the SEM allowed to dry under a mercury 
lamp for 5 min.  
TEM analysis of silver nanoparticles  
The surface morphology and size of the nanoparticles were studied 
by transmission electron microscopy (JEOL (JEM-1010) instrument) 
with an accelerating voltage of 80 KV. Silver nanoparticles were 
loaded on carbon-coated copper grids, and solvent were allowed to 
evaporate under the infra light for 30 min. The particle size and 
surface morphology of nanoparticles was evaluated using Image J 
1.45s software. 
Antibacterial activity 
The antimicrobial activity of silver nanoparticles was tested against 
the two pathogenic strains Salmonella typhi and Salmonella 
paratyphi as the method suggested by [14]. 
The mean of increase in fold area can be calculated by the mean surface 
area for the zone of inhibition of each antibiotics that has been used 
alone and antibiotic plus s
For antibacterial activity 
agar well-diffusion method was followed, 25 ml of nutrient agar 
medium was poured into sterilized petri dishes. The bacterial test 
organisms were grown in nutrient broth for 24 h. A 100 μl nutrient 
broth culture of each bacterial organism (1×105 CFU/ml) were used 
to prepare bacterial lawns. Agar wells of 8 mm diameter were 
prepared with the help of a sterilized stainless steel cork borer. The 
wells were loaded with 60 μl of silver nanoparticles solution, 60 μl of 
ceftriaxone (10 mg in 100 ml of distilled water), 60 μl of ceftriaxone 
in combination with silver nanoparticle solution, 60 μl of ofloxicin 
(10 mg in 100 ml of distilled water), and 60 μl of ofloxicin in 
combination with the silver nanoparticle solution [15]. The plates 
were incubated at 37 °C for 24 h and then were observed in the 
presence of zones of inhibition. Each inhibition zone diameter was 
measured and the mean value for each organism was recorded and 
expressed in millimeters. 
Assessment of increase in fold area 
ilver nanoparticle solution. The increase in the 
fold area of two different pathogens for antibiotics and antibiotics plus 
silver nanoparticle solution can be calculated by Fold increase 
(%) =  b−a
a
 × 100 where “a” and “b” refer to the zones of inhibition for 
antibiotic alone and antibiotic with silver nanoparticles [16]. 
RESULTS AND DISCUSSION 
Trametes sp. used in this study was isolated from Bodhan Forest 
Nizamabad District, Telangana, India. For the biosynthesis of silver 
nanoparticles. Initially the fungal cell filtrate was challenged with 
1 mM silver nitrate solution, in a 250 ml Erlenmeyer flask and 
agitated at 30 °C in dark for 72 h under static conditions at 200 
rpm and the silver nanoparticle production was monitored by the 
change in color (fig. 1) and later it was subjected to optical 
measurements by UV-Vis spectrophotometer this analysis showed 
an absorbance peak at 420 nm (fig. 2), which was specific for the 
silver nanoparticles [17]. The exact mechanism of the synthesis of 
silver nanoparticles 
FTIR analysis was used to identify the molecules, proteins and 
functional groups involved in the reduction of silver ions into silver 
nanoparticles and stabilize them as capping agent. The dried, 
powdered sample of 
was not known, but later it was hypothesized 
that that the fungal biomass contain the NADH dependent nitrate 
reductase enzyme, when the silver ions comes in contact with the 
cell wall of the fungal biomass, the nitrate reductase secreted by 
the fungus causes the reduction of silver ions into silver 
nanoparticles [18-20].  
silver nanoparticles showed the presence of 
two types of vibrations (i.e. stretching and bending) in the 
wavelength range of 4000 to 500 cm-1. The presence of an amine 
vibration band at 3400 cm-1 representing a primary amine group (N-
H) stretching and amide (N-H) bending vibration bands at 1650 and 
1644 cm-1 [21]. Furthermore, the FT-IR spectra of biologically 
synthesized silver nanoparticles also revealed peaks at 2026 and 
2116 cm-1 stretching vibrations of aliphatic C-H bonds. 
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Fig. 1: Synthesis of silver nanoparticles from Trametes sp 
 
 
Fig. 2: UV-Visible absorption spectra of silver nanoparticles 
after 48 h of incubation 
 
A band at 1412 cm-1 can be assigned to CH2-scissoring stretching 
vibration at the planar region. Several C-N stretching, vibration 
peaks at 1258, 1143, 1102, 1027 and 908 cm-1 were also observed in 
the spectral range of 1230 to 900 cm-1 (fig. 3). In addition, the 
presence of bands at 1356 and 1250 cm-1 in the FT-IR spectra 
reveals that capping agent of biologically synthesized nanoparticles 
possesses an aromatic amine group with specific identities of the 
amide linkages between amino acid residues in the proteins in the 
infrared region of the electromagnetic spectrum [22]. This type of 
FT-IR spectra indicates the presence of a protein form of the 
compound on the surface of the biologically synthesized 
nanoparticles, confirming that metabolically produced protein acted 
as capping agents during production and prevented the reduced 
silver particle agglomeration. This evidence suggests that the release 
of extracellular protein molecules could possibly perform the 
function of formation and stabilization of silver nanoparticles
 
 in 
aqueous medium.  
Fig. 3: FT-IR spectrum of the synthesized silver nanoparticles 
 
The TEM technique is used to visualize the size and shape of the 
biosynthesized silver nanoparticles 
 
as shown in (fig. 4). The 
morphology of nanoparticles is highly variable with spherical shape 
observed on micrographs. The TEM micrograph suggests that 
particle diameters ranged from 5 to 40 nm which are similar to the 
result of [23]. SEM studies revealed that the biologically synthesized 
silver nanoparticles are different in size and shape and are mostly 
observed as individual particles and aggregates. SEM mediated 
characterization of biologically synthesized nanomaterials has been 
performed by several members. Silver nanoparticles are in the size 
range of 10-40 nm with a mean diameter of 14.5 nm which was 
revealed by particle size analysis suggesting the production of 
different-sized nanoparticles (fig. 5). A range of 20-50 nm particles 
by Lactobacillus sp. [24], 35-46 nm silver nanoparticles by 
Pseudomonas stutzeri [25] have been reported.  
 
Fig. 4: SEM Micrograph of the silver nanoparticles synthesized 
from fungal extracts 
 
 
Fig. 5: TEM Micrograph of the silver nanoparticles synthesized from fungal extracts 
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It is surely understood that Ag-particles and Ag-based mixes have 
strong antimicrobial impacts [26] and number of microorganisms 
have developed medication resistance over numerous eras. Up to 
this point, these antimicrobial specialists in view of chemicals have 
been viable for treatment notwithstanding, they have been 
restricted to use for therapeutic gadgets and in prophylaxis in 
antimicrobial offices. In this way, an option approach to beat the 
medication resistance of different microorganisms is required 
urgently, particularly in therapeutic gadgets, and so forth. Silver 
nano particles particles and silver salts have been utilized for quite a 
long time as antimicrobial specialists in different fields on account of 
their development inhibitory limit against microorganisms. The 
system of the inhibitory impacts of silver nano particles on 
microorganisms is partially known. A few studies have reported that 
the positive charge on the silver nano particles is significant for its 
antimicrobial movement through the electrostatic fascination 
between negative charged cell layers of microorganism and 
positively charged nanoparticles [27, 28]. The combined effect of 
these nanoparticles with antibiotics was investigated against S. typhi 
and S. paratyphi using the disk diffusion method. The diameter of 
inhibition zones (in millimeters) around the different antibiotic 
disks with or without silver nano particles against test strains. The 
anti bacterial activity of ceftriaxone and ofloxacin increase in the 
presence of silver nano particles against test strains the increase in 
synergistic effect may be caused by the bonding reaction between 
antibiotic and nano silver. As the antibiotic molecules contain many 
active groups such as hydroxyl and amido groups, which reacts 
easily with nano silver by chelation. More recently, Batarseh 
research showed that the bactericidal effect was caused by silver (I) 
chelating, which prevents DNA from unwinding [29]. The 
antibacterial activity of ceftriaxone and ofloxacin were evaluated 
with a diameter of inhibition zones for the test bacteria (S. typhi and 
S. para typhi). The antibacterial activity of ceftriaxone and ofloxacin
 
Fig. 6: Antibacterial activity of silver nanoparticles produced by Trametes sp. conjugated with antibiotics against bacterial species 
 
increased significantly in the presence of silver nanoparticles (fig. 6). 
  
 
It was found that the silver nanoparticles produced from Trametes 
sp. enhanced the reaction rates of the antibiotics in a synergistic 
mode as well as in its own way on these pathogens. In both the cases 
of S. typhi and S. paratyphi the highest zone of inhibition was found 
in the combination of ofloxacin+silver nanoparticles followed by 
ceftriaxone+silver nanoparticles, ofloxicin, ceftriaxone and silver 
nanoparticles. (fig. 7). 
 
 
Fig. 7: Graphical representation of the combination of 
antibiotics with silver nanoparticles against the test bacteria 
 
These results are in line with the findings of Krishna et al., [17], who 
mentioned increasing efficacies (percentage) of antibiotics like 
streptomycin and ceftriaxone when used in combination with silver 
nanoparticles against Bacillus subtilis, S. aureus, E. coli and Proteus 
vulgaris. In another report by Shahnaz and Anima [28], studied that 
in vitro antibacterial activity of silver nanoparticles synthesized 
from Penicillium species were carried out and also in combination 
with the Sparfloxacin and Ofloxacin antibiotics against clinically 
isolated pathogens viz., Staphylococcus aureus, Bacillus cereus, E. coli, 
and Proteus vulgaris. It was found that the silver nano particles 
produced from Penicillium species enhanced the reaction rates of the 
antibiotics in a synergistic mode as well as in its own way on these 
clinically isolated pathogens. In other findings, the antibacterial 
activities of carbicillin and amoxicillin were amplified in the 
presence of silver nanoparticles against the bacterial strains. The 
highest increase in fold area was observed for amoxicillin against E. 
coli, Proteus vulgaris and Bacillus cereus. It was found that the silver 
nanoparticles enhanced the reaction rates of the antibiotics in a 
synergistic mode as well as in its own way on these clinically 
isolated pathogens [31]. In another study by Syed Zeeshan et al., 
[32], reported that the antibiotics ciprofloxacin and imipenem in 
combination with the silver nanoparticles and it was found to be 
most effective in inhibiting bacteria, if the bacteria increases its 
resistance to one of them, the other bactericidal agent would kill the 
bacteria. In synergism, the bactericidal effect is enhanced by 
interaction between active groups like hydroxyl and amino groups 
present in these antibiotics with silver nanoparticles by chelation. As 
a result, antibiotic-silver nanoparticles conjugate is formed in which 
a silver nanoparticle core is surrounded by antibiotic molecules. 
Thus, the antimicrobial concentration is increased at the focal site, 
which leads to increased destruction of bacteria [33]. 
From the above investigation, it was found that the silver 
nanoparticles synthesized from Trametes sp. along with antibiotics 
enhanced the antibacterial activity against test bacteria. The 
enhanced synergistic effect of biologically synthesized silver 
nanoparticles and antibiotics against pathogenic bacteria could be 
potentially applied in the development of new therapeutic agents. 
Krishna et al. 




In the present scenario, silver nanoparticles have appeared as a 
promising antibacterial candidate in the medical field. In this study, 
Trametes species were found to be an effective biological tool for the 
extracellular biosynthesis of stable silver nanoparticles. These 
biologically synthesized silver nanoparticles shows good 
antibacterial activity. The activity of ofloxacin and streptomycin was 
augmented when impregnated with silver nanoparticles. Thus, these 
nanoparticles can be used as antibacterial agents alone or with 
antibiotics and decreases the side effects. Hence, it can be concluded 
that the applications of silver nanoparticles and antibiotics together 
improved their cost
1. Anima N, Shahnaz M. Enhanced antibacterial efficacy of 
biosynthesized silver nanoparticles from Penicillium glabrum 
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